+

WO1991015498A3 - Derives nucleosidiques - Google Patents

Derives nucleosidiques Download PDF

Info

Publication number
WO1991015498A3
WO1991015498A3 PCT/EP1991/000639 EP9100639W WO9115498A3 WO 1991015498 A3 WO1991015498 A3 WO 1991015498A3 EP 9100639 W EP9100639 W EP 9100639W WO 9115498 A3 WO9115498 A3 WO 9115498A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleoside
nucleoside derivatives
compounds
purine
acyl
Prior art date
Application number
PCT/EP1991/000639
Other languages
English (en)
Other versions
WO1991015498A2 (fr
Inventor
Jo Klaveness
Kjell Undheim
Original Assignee
Holmes Michael John
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909007651A external-priority patent/GB9007651D0/en
Priority claimed from GB909007650A external-priority patent/GB9007650D0/en
Priority claimed from GB909007566A external-priority patent/GB9007566D0/en
Application filed by Holmes Michael John, Nycomed As filed Critical Holmes Michael John
Priority to JP91506841A priority Critical patent/JPH05505815A/ja
Priority to CA002079796A priority patent/CA2079796A1/fr
Publication of WO1991015498A2 publication Critical patent/WO1991015498A2/fr
Publication of WO1991015498A3 publication Critical patent/WO1991015498A3/fr
Priority to NO92923849A priority patent/NO923849L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Composés nucléosidiques répondant à la formule (I): Y1O-G-X dans laquelle Y1 est un atome d'hydrogène ou un groupe acyle ou acyloxyméthyle; G est le résidu de la moitié glycone du nucléoside; et X est une base de purine ou de pyrimidine ou un dérivé ester, amide ou acyloxyalkyle de cette base. Les composés présentent une activité antivirale.
PCT/EP1991/000639 1990-04-04 1991-04-04 Derives nucleosidiques WO1991015498A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP91506841A JPH05505815A (ja) 1990-04-04 1991-04-04 ヌクレオシド誘導体
CA002079796A CA2079796A1 (fr) 1990-04-04 1991-04-04 Derives de nucleosides
NO92923849A NO923849L (no) 1990-04-04 1992-10-02 Nukleosid-derivater

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB909007651A GB9007651D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
GB909007650A GB9007650D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
GB9007566.4 1990-04-04
GB909007566A GB9007566D0 (en) 1990-04-04 1990-04-04 Nucleoside derivatives
GB9007651.4 1990-04-04
GB9007650.6 1990-04-04

Publications (2)

Publication Number Publication Date
WO1991015498A2 WO1991015498A2 (fr) 1991-10-17
WO1991015498A3 true WO1991015498A3 (fr) 1992-06-11

Family

ID=27265029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/000639 WO1991015498A2 (fr) 1990-04-04 1991-04-04 Derives nucleosidiques

Country Status (6)

Country Link
EP (1) EP0523110A1 (fr)
JP (1) JPH05505815A (fr)
AU (1) AU7558491A (fr)
CA (1) CA2079796A1 (fr)
OA (1) OA09677A (fr)
WO (1) WO1991015498A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45288E1 (en) 2008-04-18 2014-12-09 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
US9102681B2 (en) 2008-04-18 2015-08-11 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
US9233998B2 (en) 2008-04-18 2016-01-12 Reata Pharmaceuticals, Inc. Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
US9249089B2 (en) 2008-04-18 2016-02-02 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2073063A1 (fr) * 1989-11-06 1991-05-07 Jo Klaveness Derives nucleosidiques
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
JPH0692987A (ja) * 1992-09-17 1994-04-05 Tanabe Seiyaku Co Ltd ウリジン誘導体およびその製法
JPH11217396A (ja) * 1998-01-30 1999-08-10 Ajinomoto Co Inc ヌクレオシド誘導体の製造方法
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
US7265096B2 (en) 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN1693309A (zh) * 2005-04-18 2005-11-09 成都正开生物科技发展有限公司 N4－（取代的氧羰基）－2′，2′－二氟－2′－脱氧胞苷衍生物及其应用
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008064132A2 (fr) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Triterpénoïdes synthétiques et bis-énones tricycliques pour une utilisation dans la stimulation de croissance osseuse et cartilagineuse
WO2008064133A1 (fr) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthèse et activités biologiques de nouveaux composés tricycliques-bis-énones (tbe)
TWI492745B (zh) 2008-01-11 2015-07-21 Reata Pharmaceuticals Inc 合成的三萜系化合物及其使用於治療疾病之方法
WO2009146216A2 (fr) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Modulateurs d’inflammation antioxydant : nouveaux dérivés d’acide oléanolique
KR101626703B1 (ko) 2012-04-04 2016-06-02 할로자임, 아이엔씨 항-히알루로난 제제 및 종양-표적 탁산을 이용한 병용 치료
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2016078160A1 (fr) * 2014-11-17 2016-05-26 常州方圆制药有限公司 Dérivé de cytidine et application de celui-ci
WO2016078397A1 (fr) * 2014-11-17 2016-05-26 常州方圆制药有限公司 Nouveau type de dérivé de cytidine et application de celui-ci
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
GR1009958B (el) * 2019-04-24 2021-03-18 ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651045A (en) * 1968-10-21 1972-03-21 Parke Davis & Co 9-(beta-d-arabinofuranosyl)adenine esters and methods for their production
EP0042596A1 (fr) * 1980-06-23 1981-12-30 The Regents Of The University Of Minnesota Dérivés d'adénosine, leur préparation et compositions pharmaceutiques les contenant
EP0056265A2 (fr) * 1981-01-09 1982-07-21 Dr. Thilo & Co. GmbH Pyrimidinenucléosides estérifiés en position 5' ayant une activité antivirale, méthode pour leur préparation et les médicaments les contenant
EP0104857A1 (fr) * 1982-09-28 1984-04-04 Beecham Group Plc Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
EP0151189A1 (fr) * 1983-07-20 1985-08-14 Teijin Limited Agent antineoplastique
EP0217580A2 (fr) * 1985-09-17 1987-04-08 The Wellcome Foundation Limited Nucléosides thérapeutiques
EP0219829A2 (fr) * 1985-10-18 1987-04-29 Sloan-Kettering Institute For Cancer Research Nucléosides 2-fluoro-arabinofuranosyl purine
EP0260852A2 (fr) * 1986-09-08 1988-03-23 The Wellcome Foundation Limited Analogues aux nucléosides
WO1988007532A1 (fr) * 1987-03-24 1988-10-06 Nycomed A.S. Derives d'oxyde de 2',3' didesoxyribofuranne
EP0329348A2 (fr) * 1988-02-16 1989-08-23 Eli Lilly And Company Nucléosides-2',3'-didéoxy-2',2'-difluoro
EP0340778A2 (fr) * 1988-05-06 1989-11-08 Bristol-Myers Squibb Company Prodrogues de 2',3'-didéshydro-2',3'-didésoxynucléosides
EP0341704A2 (fr) * 1988-05-12 1989-11-15 F. Hoffmann-La Roche Ag Procédé pour la préparation de 2',3'-didéoxycytidines
EP0346108A2 (fr) * 1988-06-09 1989-12-13 The Wellcome Foundation Limited Nucléosides anti-infectieux
EP0355031A2 (fr) * 1988-08-17 1990-02-21 MATTHES, Eckart, Dr. Nucléosides pyrimidiniques substitués, leur procédé de préparation et médicaments les contenant
EP0362967A1 (fr) * 1988-10-05 1990-04-11 Nycomed Imaging As Dérivés de nucléosides
EP0366171A1 (fr) * 1988-10-05 1990-05-02 Nycomed As Dérivés de nucléosides
EP0417999A1 (fr) * 1989-09-11 1991-03-20 The Wellcome Foundation Limited Composés antiviraux

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651045A (en) * 1968-10-21 1972-03-21 Parke Davis & Co 9-(beta-d-arabinofuranosyl)adenine esters and methods for their production
EP0042596A1 (fr) * 1980-06-23 1981-12-30 The Regents Of The University Of Minnesota Dérivés d'adénosine, leur préparation et compositions pharmaceutiques les contenant
EP0056265A2 (fr) * 1981-01-09 1982-07-21 Dr. Thilo & Co. GmbH Pyrimidinenucléosides estérifiés en position 5' ayant une activité antivirale, méthode pour leur préparation et les médicaments les contenant
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
EP0104857A1 (fr) * 1982-09-28 1984-04-04 Beecham Group Plc Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine
EP0151189A1 (fr) * 1983-07-20 1985-08-14 Teijin Limited Agent antineoplastique
EP0217580A2 (fr) * 1985-09-17 1987-04-08 The Wellcome Foundation Limited Nucléosides thérapeutiques
EP0219829A2 (fr) * 1985-10-18 1987-04-29 Sloan-Kettering Institute For Cancer Research Nucléosides 2-fluoro-arabinofuranosyl purine
EP0260852A2 (fr) * 1986-09-08 1988-03-23 The Wellcome Foundation Limited Analogues aux nucléosides
WO1988007532A1 (fr) * 1987-03-24 1988-10-06 Nycomed A.S. Derives d'oxyde de 2',3' didesoxyribofuranne
EP0329348A2 (fr) * 1988-02-16 1989-08-23 Eli Lilly And Company Nucléosides-2',3'-didéoxy-2',2'-difluoro
EP0340778A2 (fr) * 1988-05-06 1989-11-08 Bristol-Myers Squibb Company Prodrogues de 2',3'-didéshydro-2',3'-didésoxynucléosides
EP0341704A2 (fr) * 1988-05-12 1989-11-15 F. Hoffmann-La Roche Ag Procédé pour la préparation de 2',3'-didéoxycytidines
EP0346108A2 (fr) * 1988-06-09 1989-12-13 The Wellcome Foundation Limited Nucléosides anti-infectieux
EP0355031A2 (fr) * 1988-08-17 1990-02-21 MATTHES, Eckart, Dr. Nucléosides pyrimidiniques substitués, leur procédé de préparation et médicaments les contenant
EP0362967A1 (fr) * 1988-10-05 1990-04-11 Nycomed Imaging As Dérivés de nucléosides
EP0366171A1 (fr) * 1988-10-05 1990-05-02 Nycomed As Dérivés de nucléosides
EP0417999A1 (fr) * 1989-09-11 1991-03-20 The Wellcome Foundation Limited Composés antiviraux

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45288E1 (en) 2008-04-18 2014-12-09 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
USRE45325E1 (en) 2008-04-18 2015-01-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
US9102681B2 (en) 2008-04-18 2015-08-11 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
US9233998B2 (en) 2008-04-18 2016-01-12 Reata Pharmaceuticals, Inc. Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
US9249089B2 (en) 2008-04-18 2016-02-02 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Also Published As

Publication number Publication date
WO1991015498A2 (fr) 1991-10-17
JPH05505815A (ja) 1993-08-26
OA09677A (en) 1993-05-15
EP0523110A1 (fr) 1993-01-20
CA2079796A1 (fr) 1991-10-05
AU7558491A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
WO1991015498A3 (fr) Derives nucleosidiques
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
AU7810791A (en) Derivatives of (hydroxymethyl)cyclobutane
CA2297294A1 (fr) Derives de phosphonomethoxymethylpurine/pyrimidine
BR0011521B1 (pt) Compostos nucleósidos de purina de 4 -c-etinila
AU1489388A (en) 2',3' dideoxyribofuranoxide derivatives
CA2062299A1 (fr) Derives du cyclopropane
MY103801A (en) Dideoxydidehydrocarbocyclic nucleosides
AU4333889A (en) Nucleoside derivatives
EP0770621A4 (fr) 2'-desoxy-2'-(methylidene substitue ou non substitue)-4'-thionucleoside
AU4425589A (en) Nucleoside derivatives
EP0598910A4 (fr) Procede de production de derive de nucleosides.
HUT54153A (en) Process for producing purinyl- and pyrimidinyltetrahydrofuran derivatives and pharmaceutical compositions comprising same
EP0155164A3 (en) Novel cyanoimidazole nucleoside derivatives
CA2188306A1 (fr) Methode pour la synthese diastereoselective d'analogues de nucleosides
MX9604880A (es) Procedimiento para la sintesis diasteroselectiva de analogos de nucleosido.
EP0381533A3 (fr) Monophosphates cycliques d'acyclonucléosides de purine et de pyrimidine
EP0246529A3 (fr) Dérivés de pyrrolo[2,3-g]isoquinolein-4-one à activité prolongée
WO1990005730A3 (fr) Nouveaux derives de cyclobutane et procede de production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP NO US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.24/91,UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI JP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2079796

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991906957

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991906957

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991906957

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载